2024-04-16 17:45:00 ET
The latest earnings season has begun, and the latest quarterly results from some of our economy's largest companies are starting to come in.
Tuesday morning, it was healthcare mainstay Johnson & Johnson 's (NYSE: JNJ) turn in the spotlight, and investors weren't all that satisfied with the performance. In the wake of the company's first-quarter earnings report, the stock traded down by over 2%. That was a steeper fall than the 0.2% decline of the S&P 500 index on the day.
In its first quarter, Johnson & Johnson earned $21.38 billion in sales, which was more than 2% higher on a year-over-year basis. Non- GAAP (adjusted) net income also edged higher, rising by nearly 4% to $6.58 billion, or $2.71 per share.
For further details see:
Why Johnson & Johnson Stock Got Tossed by the Market Today